Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:28:27.040Z.
Calculation as of: 2026-10-06T19:28:27.040Z.
Quote observation: 2026-10-06T19:25:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a8ce9bd0ffb1cb5d8a686ad50c5c0fc76176a0385911c5cc34bdb5d73fbb2f35
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-01-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$180.89M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$181.89M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.94M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.18M
EV/EBITDA Ratio
136.35x
TTM Avg
155.63x
3Y Avg
70.41x
5Y Avg
70.41x
Market Cap
$171.41M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Yarrow Bioscience Inc (YARW) | $177.71M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $180.89M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $181.89M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.29M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.94M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.22M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $172.18M | 136.35x | 155.63x | 70.41x | 70.41x |
| Precision BioSciences, Inc. (DTIL)vs › | $171.41M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $168.48M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $188.72M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2022-01-12 | 0.00x |
| 2022-01-11 | 0.01x |
| 2022-01-10 | 0.00x |
| 2022-01-07 | 0.00x |
| 2022-01-06 | 0.00x |
| 2022-01-05 | 0.01x |
| 2022-01-04 | 0.02x |
| 2022-01-03 | 0.02x |
| 2021-12-31 | 0.00x |
| 2021-12-30 | 0.01x |
| 2021-12-29 | 0.00x |
| 2021-12-28 | 0.01x |
| 2021-12-27 | 0.01x |
| 2021-12-23 | 0.02x |
| 2021-12-22 | 0.01x |
| 2021-12-21 | 0.02x |
| 2021-12-20 | 0.01x |
| 2021-12-17 | 0.01x |
| 2021-12-16 | 0.01x |
| 2021-12-15 | 0.02x |
| 2021-12-14 | 0.02x |
| 2021-12-13 | 0.03x |
| 2021-12-10 | 0.06x |
| 2021-12-09 | 0.05x |
| 2021-12-08 | 0.03x |
| 2021-12-07 | 0.02x |
| 2021-12-06 | 0.02x |
| 2021-11-30 | 0.01x |
| 2021-11-29 | 0.00x |
| 2021-11-26 | 0.01x |
| 2021-11-24 | 0.01x |
| 2021-11-23 | 0.00x |
| 2021-11-22 | 0.01x |
| 2021-11-19 | 0.01x |
| 2021-11-18 | 0.01x |
| 2021-11-17 | 0.02x |
| 2021-11-16 | 0.03x |
| 2021-11-15 | 0.03x |
| 2021-11-12 | 0.04x |
| 2021-11-11 | 0.04x |
| 2021-11-09 | 0.00x |
| 2021-11-08 | 0.00x |
| 2021-11-05 | 0.00x |
| 2021-11-04 | 0.00x |
| 2021-11-03 | 0.01x |
| 2021-11-02 | 0.01x |
| 2021-11-01 | 0.01x |
| 2021-10-29 | 0.00x |
| 2021-10-26 | 0.00x |
| 2021-10-01 | 0.01x |
| 2021-09-30 | 0.01x |
| 2021-09-29 | 0.01x |
| 2021-09-28 | 0.02x |
| 2021-09-27 | 0.02x |
| 2021-09-24 | 0.02x |
| 2021-09-23 | 0.02x |
| 2021-09-22 | 0.01x |
| 2021-09-21 | 0.01x |
| 2021-09-20 | 0.01x |
| 2021-09-17 | 0.02x |
| 2021-09-16 | 0.02x |
| 2021-09-15 | 0.01x |
| 2021-09-14 | 0.01x |
| 2021-09-13 | 0.02x |
| 2021-09-10 | 0.02x |
| 2021-09-09 | 0.03x |
| 2021-09-08 | 0.03x |
| 2021-09-07 | 0.03x |
| 2021-09-03 | 0.04x |
| 2021-09-02 | 0.04x |
| 2021-09-01 | 0.04x |
| 2021-08-31 | 0.04x |
| 2021-08-30 | 0.04x |
| 2021-08-27 | 0.03x |
| 2021-08-26 | 0.02x |
| 2021-08-25 | 0.03x |
| 2021-08-24 | 0.03x |
| 2021-08-23 | 0.02x |
| 2021-08-20 | 0.01x |
| 2021-08-19 | 0.01x |
| 2021-08-18 | 0.02x |
| 2021-08-17 | 0.03x |
| 2021-08-16 | 0.05x |
| 2021-08-13 | 0.05x |
| 2021-08-12 | 0.04x |
| 2021-08-11 | 0.17x |
| 2021-08-10 | 0.15x |
| 2021-08-09 | 0.15x |
| 2021-08-06 | 0.13x |
| 2021-08-05 | 0.13x |
| 2021-08-04 | 0.14x |
| 2021-08-03 | 0.14x |
| 2021-08-02 | 0.15x |
| 2021-07-30 | 0.15x |
| 2021-07-29 | 0.16x |
| 2021-07-28 | 0.15x |
| 2021-07-27 | 0.15x |
| 2021-07-26 | 0.15x |
| 2021-07-23 | 0.15x |
| 2021-07-22 | 0.16x |
| 2021-07-21 | 0.18x |
| 2021-07-20 | 0.16x |
| 2021-07-19 | 0.15x |
| 2021-07-16 | 0.14x |
| 2021-07-15 | 0.15x |
| 2021-07-14 | 0.18x |
| 2021-07-13 | 0.19x |
| 2021-07-12 | 0.19x |
| 2021-07-09 | 0.21x |
| 2021-07-08 | 0.20x |
| 2021-07-07 | 0.20x |
| 2021-07-06 | 0.21x |
| 2021-07-02 | 0.23x |
| 2021-07-01 | 0.26x |
| 2021-06-30 | 0.27x |
| 2021-06-29 | 0.28x |
| 2021-06-28 | 0.29x |
| 2021-06-25 | 0.30x |
| 2021-06-24 | 0.30x |
| 2021-06-23 | 0.28x |
| 2021-06-22 | 0.28x |
| 2021-06-21 | 0.28x |
| 2021-06-18 | 0.29x |
| 2021-06-17 | 0.29x |
| 2021-06-16 | 0.30x |
| 2021-06-15 | 0.29x |
| 2021-06-14 | 0.31x |
| 2021-06-11 | 0.34x |
| 2021-06-10 | 0.35x |
| 2021-06-09 | 0.35x |
| 2021-06-08 | 0.35x |
| 2021-06-07 | 0.34x |
| 2021-06-04 | 0.31x |
| 2021-06-03 | 0.33x |
| 2021-06-02 | 0.33x |
| 2021-06-01 | 0.34x |
| 2021-05-28 | 0.33x |
| 2021-05-27 | 0.29x |
| 2021-05-26 | 0.28x |
| 2021-05-25 | 0.26x |
| 2021-05-24 | 0.27x |
| 2021-05-21 | 0.29x |
| 2021-05-20 | 0.30x |
| 2021-05-19 | 0.29x |
| 2021-05-18 | 0.31x |
| 2021-05-17 | 0.28x |
| 2021-05-14 | 0.27x |
| 2021-05-13 | 0.23x |
| 2021-05-12 | 0.26x |
| 2021-05-11 | 0.25x |
| 2021-05-10 | 0.24x |
| 2021-05-07 | 0.28x |
| 2021-05-06 | 0.43x |
| 2021-05-05 | 0.56x |
| 2021-05-04 | 0.58x |
| 2021-05-03 | 0.63x |
| 2021-04-30 | 0.62x |
| 2021-04-29 | 0.65x |
| 2021-04-28 | 0.66x |
| 2021-04-27 | 0.66x |
| 2021-04-26 | 0.67x |
| 2021-04-23 | 0.65x |
| 2021-04-22 | 0.66x |
| 2021-04-21 | 0.65x |
| 2021-04-20 | 0.60x |
| 2021-04-19 | 0.65x |
| 2021-04-16 | 0.68x |
| 2021-04-15 | 0.69x |
| 2021-04-14 | 0.72x |
| 2021-04-13 | 0.72x |
| 2021-04-12 | 0.76x |
| 2021-04-09 | 0.77x |
| 2021-04-08 | 0.82x |
| 2021-04-07 | 0.83x |
| 2021-04-06 | 0.87x |
| 2021-04-05 | 0.87x |
| 2021-04-01 | 0.90x |
| 2021-03-31 | 0.89x |
| 2021-03-30 | 0.85x |
| 2021-03-29 | 0.83x |
| 2021-03-26 | 0.89x |
| 2021-03-25 | 0.89x |
| 2021-03-24 | 0.88x |
| 2021-03-23 | 0.92x |
| 2021-03-22 | 0.97x |
| 2021-03-19 | 1.03x |
| 2021-03-18 | 0.97x |
| 2021-03-17 | 1.02x |
| 2021-03-16 | 0.96x |
| 2021-03-15 | 0.95x |
| 2021-03-12 | 0.96x |
| 2021-03-11 | 0.96x |
| 2021-03-10 | 0.90x |
| 2021-03-09 | 0.90x |
| 2021-03-08 | 0.82x |
| 2021-03-05 | 0.86x |